Manish A. Shah, MD, on Gastric Cancer: Results From the RAINFALL Trial

2018 Gastrointestinal Cancers Symposium
Tweet this page

Manish A. Shah, MD, of Weill Cornell Medicine, discusses phase III study findings on cisplatin plus capecitabine or fluorouracil with or without ramucirumab as first-line therapy in patients with metastatic gastric or gastroesophageal junction adenocarcinoma (Abstract 5).

Advertisement

Advertisement



Advertisement